Reuters logo
BRIEF-Vexim announces another major step towards SpineJack commercialization in US
February 21, 2017 / 7:15 AM / 10 months ago

BRIEF-Vexim announces another major step towards SpineJack commercialization in US

Feb 21 (Reuters) - Vexim SA:

* Finalizes recruitment of patients for international clinical study, supporting the 510 (k) regulatory approval application to the FDA

* Submission of the regulatory dossier planned by the end of 2017, for a probable launch in the United States in the first half of 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below